Skip to main content

Table 3 Correlation of tumor subgroups with clinical parameters

From: Colon cancer molecular subtypes identified by expression profiling and associatedto stroma, mucinous type and different clinical behavior

Parameter

 

Cluster-1 (n = 35)

Cluster-2 (n = 12)

Cluster-3 (n = 22)

Cluster-4 (n = 14)

p-global

Microsatellite instability

MSS

33

11

21

9

0.039LR,a

 

MSI

2

1

1

5

 

Histologic subtypes

Conventional

34

12

21

8

0.001LR,b

 

Mucinous

1

0

1

6

 

% Stroma content frozen sample

Mean

11.2

18.8

23.4

18.9

<0.001KW,c

 

SD

6.0

10.3

10.5

14.8

 

% Stroma Paraffin

Mean

12.6

17.1

18.9

16.8

0.047KW,d

 

SD

6.0

9.9

8.6

14.2

 

nuclear β-Catenin (IHC)

LOW

21

9

11

12

0.021LR,e

 

MEDIUM

4

0

6

1

 
 

HIGH

10

2

5

0

 

BRAF mutations (V600E)

Mutated

0

1

1

6

<0.001LR,f

 

WT

35

11

21

8

 

Dukes Stage

A

9

5

4

4

0.646LR

 

B

9

3

6

7

 
 

C

8

2

6

2

 
 

D

9

2

6

1

 
  1. LR: Likelihood Ratio. KW: Kruskal Wallis. Pair wise comparisons: a:C4 ≠ C1 (0.015); C4 ≠ C3(0.024); b: C4 ≠ C1 (0.001);C2 ≠ C4 (0.017); C4 ≠ C3(0.008); c: C1 ≠ C4 (0.013);C1 ≠ C2 (0.020); C1 ≠ C3 (<0.001); d: C1 ≠ C3 (0.005); e:C1 ≠ C4 (0.020); C2 ≠ C3(0.047); C3 ≠ C4 (0.014); f:C4 ≠ C1 (<0.001); C4 ≠ C2(<0.081); C4 ≠ C3 (0.008); Frozen stroma vsparaffin ICC of 0.781 (IC95% 0.681-0.852)p < 0.001.